← Back to patent-cliff list
CAS 14805-29-9
exo-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dioneexo-Norbornane-2,3-dicarboximide
Codes：LURA-024
Application context (from source-drug indications)
重度抑郁症盐酸鲁拉西酮精神分裂症盐酸鲁拉西酮躁狂症盐酸鲁拉西酮抑郁症盐酸鲁拉西酮
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 盐酸鲁拉西酮Lurasidone Hydrochloride | Tier B — Position early | 2028 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
exo-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dioneexo-Norbornane-2,3-dicarboximide→[(1R,2R)-2-[[4-(1,2-Benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl methanesulfonate
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications |
|---|---|---|---|---|---|
| Unibest Taizhou GMP-like Site | (3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.